References
1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38:S512-21.
2. Lee L, Smith-Whitley K, Banks S, Puckrein G. Reducing Health Care Disparities in Sickle Cell Disease: A Review. Public Health Rep 2019;134:599-607.
3. Fernandez CR, Licursi M, Wolf R, Lee MT, Green NS. Food insecurity, housing instability, and dietary quality among children with sickle cell disease: Assessment from a single urban center. Pediatr Blood Cancer 2021:e29463.
4. Cronin RM, Hankins JS, Byrd J, et al. Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study. Hematology 2019;24:189-98.
5. Sil S, Woodward KE, Johnson YL, Dampier C, Cohen LL. Parental Psychosocial Distress in Pediatric Sickle Cell Disease and Chronic Pain. J Pediatr Psychol 2021;46:557-69.
6. Yarboi J, Compas BE, Brody GH, et al. Association of social-environmental factors with cognitive function in children with sickle cell disease. Child Neuropsychol 2017;23:343-60.
7. Jonassaint CR, Jones VL, Leong S, Frierson GM. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haematol 2016;174:136-47.
8. Varni JW, Panepinto JA. Cognitive functioning, patient health communication, and worry mediate pain predictive effects on health-related quality of life in youth with sickle cell disease. Pediatr Blood Cancer 2020;67:e28680.
9. Kim B, Rundle AG, Goodwin ATS, et al. COVID-19 testing, case, and death rates and spatial socio-demographics in New York City: An ecological analysis as of June 2020. Health Place 2021;68:102539.
10. Lee CM, Cadigan JM, Rhew IC. Increases in Loneliness Among Young Adults During the COVID-19 Pandemic and Association With Increases in Mental Health Problems. J Adolesc Health 2020;67:714-7.
11. Nagata JM, Ganson KT, Whittle HJ, et al. Food Insufficiency and Mental Health in the U.S. During the COVID-19 Pandemic. Am J Prev Med 2021;60:453-61.
12. Jia H, Guerin RJ, Barile JP, et al. National and State Trends in Anxiety and Depression Severity Scores Among Adults During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep 2021;70:1427-32.
13. Singh A, Brandow AM, Panepinto JA. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv 2021;5:1915-21.
14. Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020. Emerg Infect Dis 2020;26:2473-6.
15. Smaldone A, Manwani D, Aygun B, et al. HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol. BMC Pediatr 2019;19:354.
16. Dampier C, Barry V, Gross HE, et al. Initial Evaluation of the Pediatric PROMIS(R) Health Domains in Children and Adolescents With Sickle Cell Disease. Pediatr Blood Cancer 2016;63:1031-7.
17. Fletcher KM, Espey J, Grossman MK, et al. Social vulnerability and county stay-at-home behavior during COVID-19 stay-at-home orders, United States, April 7-April 20, 2020. Ann Epidemiol 2021;64:76-82.
18. Karaye IM, Horney JA. The Impact of Social Vulnerability on COVID-19 in the U.S.: An Analysis of Spatially Varying Relationships. Am J Prev Med 2020;59:317-25.
19. McGinty EE, Presskreischer R, Han H, Barry CL. Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020. JAMA 2020;324:93-4.
20. Hartline-Grafton H, Hassink SG. Food Insecurity and Health: Practices and Policies to Address Food Insecurity among Children. Acad Pediatr 2021;21:205-10.
21. Krull KR, McDonald A, Goodman P, et al. Impact of COVID-19 pandemic on a large cohort of adult survivors of childhood cancer. Pediatr Blood Cancer 2021;68:e29324.
22. Badawy SM, Thompson AA, Penedo FJ, Lai JS, Rychlik K, Liem RI. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease. Eur J Haematol 2017;98:608-14.
23. Zheng K, Abraham C, Bruzzese JM, Smaldone A. Longitudinal Relationships Between Depression and Chronic Illness in Adolescents: An Integrative Review. J Pediatr Health Care 2020;34:333-45.
24. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
25. Badawy SM, Barrera L, Cai S, Thompson AA. Association between Participants’ Characteristics, Patient-Reported Outcomes, and Clinical Outcomes in Youth with Sickle Cell Disease. Biomed Res Int 2018;2018:8296139.
26. Osunkwo I, Andemariam B, Minniti CP, et al. Impact of sickle cell disease on patients’ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol 2021;96:404-17.
27. Czeisler ME, Lane RI, Petrosky E, et al. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1049-57.
28. McKnight-Eily LR, Okoro CA, Strine TW, et al. Racial and Ethnic Disparities in the Prevalence of Stress and Worry, Mental Health Conditions, and Increased Substance Use Among Adults During the COVID-19 Pandemic - United States, April and May 2020. MMWR Morb Mortal Wkly Rep 2021;70:162-6.
29. Loades ME, Chatburn E, Higson-Sweeney N, et al. Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19. J Am Acad Child Adolesc Psychiatry 2020;59:1218-39 e3.
30. Power-Hays A, Li S, Mensah A, Sobota A. Universal screening for social determinants of health in pediatric sickle cell disease: A quality-improvement initiative. Pediatr Blood Cancer 2020;67:e28006.